MedTrace Logo

Vascularized Composite Bladder Allograft Transplantation

NCT05462561 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2026-01-20

No results posted yet for this study

Summary

This phase 0 trial tests the feasibility, functionality, and sustainability of vascularized composite bladder allograft transplantation in treating patients with terminal bladder pathology. A vascularized bladder allograft transplantation may provide a more durable and better-tolerated alternative to standard urinary diversion, which employs bowel. A robotic surgical approach will be employed.

Conditions

  • Neurogenic Bladder
  • Bladder Dysfunction
  • Immunosuppression

Interventions

OTHER

Quality-of-Life Assessment

Ancillary studies

PROCEDURE

Robotic Vascularized Composite Bladder Allograft Transplantation

Undergo robotic VCBA transplantation.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Inderbir Gill · University of Southern California

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2027-10-03
Completion
2028-10-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05462561 on ClinicalTrials.gov